share_log

华润三九(000999.SZ):预计24年下半年感冒药产能紧张状况会有所缓解

China Resources Sanjiu Medical & Pharmaceutical (000999.SZ): It is expected that the tight situation of cold medicine production capacity in the second half of 2024 will be alleviated to some extent.

Gelonghui Finance ·  03:23

Gelonghui July 30丨China Resources 39 (000999.SZ) said at an investor relations event that the company's cold category has continued to be booming in supply and sales over the past year, and production capacity is under certain pressure. At the end of '23, China Resources 39 (Chenzhou) South China manufacturing center began operation, and production capacity was gradually released during the climbing process. It is expected that the tight production capacity situation for cold medicines will ease somewhat in the second half of '24.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment